ReviewAnimals : an open access journal from MDPI2026
The Chornobyl Dogs: Why Scientific Evaluation Must Accompany Population Management.
Review in Animals : an open access journal from MDPI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nearly four decades after the 1986 reactor explosion, several hundred semi-feral dogs persist within the Chornobyl Exclusion Zone. Genomic work has characterised their population structure and shown that radiation-induced mutation does not, on current evidence, drive the differentiation between groups; the cause of that differentiation remains unresolved, and their epigenome has never been examined. These dogs are a potentially valuable model for chronic, low-dose, multi-stressor exposure, not because they are "radiation-adapted", a contested claim, but because they are a human-adjacent, densely sampled, pedigreed mammal for which comparative canine-human tools already exist. Since 2017, a humane sterilisation programme, carried out at the request of and in cooperation with the Ukrainian authorities, has reached near-complete coverage of the established populations. That programme was justified: dogs are formally prohibited in the zone, they injure workers, free-roaming animals inside an operating nuclear facility raise security as well as veterinary concerns, and reproduction was outpacing what the environment could support. Our argument concerns timing rather than policy. The scientific value of this population was never evaluated while it was still breeding, and the archived material that does exist, roughly 400 dogs including parent-offspring trios and repeat-sampled individuals, was assembled for population genetics rather than for the regulatory questions now worth asking. That archive should be analysed for methylation and expression now, as this is the only access to the population as it was. The animals themselves have not gone: several hundred identified dogs are still alive there, so sampling at veterinary contact and the retention of tissue at natural death or clinically indicated euthanasia remain possible, provided they are planned and funded in advance rather than improvised. More generally, the scientific evaluation of a population should accompany the decision to manage it rather than follow it, because sterilisation is not reversible at the population scale and an archive cannot be assembled retrospectively. We set out what such an evaluation requires at the outset of a programme. Its most concrete element asks nothing of the animals: a sterilisation clinic is the only routine access to a free-roaming population under anaesthesia, and the reproductive tissue it removes-the one material capable of addressing germline questions-is discarded as surgical waste.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.